4//SEC Filing
LYONS GARY A 4
Accession 0000914475-24-000195
CIK 0000914475other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 5:21 PM ET
Size
9.1 KB
Accession
0000914475-24-000195
Insider Transaction Report
Form 4
LYONS GARY A
Director
Transactions
- Sale
Common Stock
2024-08-13$150.43/sh−11,570$1,740,450→ 119,047 total - Exercise/Conversion
Common Stock
2024-08-13$42.76/sh+11,570$494,733→ 130,617 total - Exercise/Conversion
Non-Qualified Stock Option
2024-08-13−11,570→ 0 totalExercise: $42.76Exp: 2025-05-28→ Common Stock (11,570 underlying)
Footnotes (4)
- [F1]113,064 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.
- [F2]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2024
- [F3]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $151.30. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range
- [F4]The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001123343
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 5:21 PM ET
- Size
- 9.1 KB